In this study, solid-phase binding assay revealed that IgG from six of eight (75%) patients with ICI-induced colitis with anti-integrin αvβ6 autoantibodies blocked integrin αvβ6-fibronectin binding (Fig. 4a, Supplementary Fig. S4b). The gene discussed is FN1; the disease is colitis.